SCHEMBL8143264

SCHEMBL8143264

Cc1nc2c([nH]1)c(=O)n(CCCC[C@H](C)O)c(=O)n2Cc1ccco1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.67
LMNA P02545 1/20 0.67
CYP1A1 P04798 1/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
NFKB1 P19838 1/20 0.67
MAPK1 P28482 1/20 0.67
CYP2C19 P33261 1/20 0.67
BLM P54132 1/20 0.67
PMP22 Q01453 1/20 0.67
KMT2A Q03164 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
HIF1A Q16665 1/20 0.67
ADORA2B P29275 13/20 0.55
ADORA2A P29274 9/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8128166 1.00 MEN1 (0.67) MEN1LMNACYP1A1CYP1A2CYP3A4
SCHEMBL8128164 1.00 MEN1 (0.67) MEN1LMNACYP1A1CYP1A2CYP3A4
Furafylline SCHEMBL191214 0.81 MEN1 (1.00) MEN1LMNACYP1A1CYP1A2CYP3A4
SCHEMBL681895 0.79 ADORA2A (0.47) LMNACYP1A2CYP3A4NFKB1MAPK1
SCHEMBL6345924 0.79 ADORA2A (0.47) LMNACYP1A2CYP3A4NFKB1MAPK1
SCHEMBL8128491 0.78 PDE2A (0.54) MEN1LMNACYP1A1CYP1A2CYP3A4
SCHEMBL8126523 0.78 PDE2A (0.54) MEN1LMNACYP1A1CYP1A2CYP3A4
SCHEMBL8126108 0.78 PDE2A (0.54) MEN1LMNACYP1A1CYP1A2CYP3A4
SCHEMBL9429916 0.73 PDE2A (0.53) CYP1A2CYP3A4MAPK1PMP22ADORA2B
SCHEMBL8142359 0.72 MEN1 (0.67) MEN1LMNACYP1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6075029-A Xanthine modulators of metabolism of cellular P-450 CELL THERAPEUTICS, INC. (US) 2000-06-13 US disclosed
WO-1999035148-A1 COMPOUNDS FOR INCREASED BIOAVAILABILITY CELL THERAPEUTICS, INC. (US) 1999-07-15 WO disclosed